IBM Watson detected a rare form of leukemia in a patient in Japan, after comparing genetic changes with a database of 20 million research papers. She had been misdiagnosed by doctors for months, and received the wrong treatment for her cancer type.
Watson has created partnerships with 16 US health systems and imaging firms to identify cancer, diabetes and heart disease. It has just announced a similar partnership with 21 hospitals in China.
While AI systems still occasionally make mistakes, the trend of using the technology for diagnosis, and personalized treatment, with suggested therapies based on assumptions of success, is growing rapidly.
Wearable Tech + Digital Health + NeuroTech Silicon Valley – February 7-8, 2017 @ Stanford University